Jarden Increases Buybacks & 3 Stocks Hitting 52-Week Highs

Harvard Bioscience (NASDAQ:HBIO) Closing price on Thursday: $5.75

The firm posted its fourth-quarter revenue at $28.2 million, compared to one estimate of $29.2 million. Also, the company reported fourth-quarter adjusted earnings from continuing operations for its core Life Science Research Tools unit at 10 cents. Shares closed down 0.69 percent on the day at $5.75, and have been traded in a 52-week range of $3.45 to $5.86.

The stock market is roaring back in 2013. Click here now to discover winning stocks!

hbio

To contact the reporter on this story: staff.writers@wallstcheatsheet.com To contact the editor responsible for this story: editors@wallstcheatsheet.com

Premium Newsletters

Stock Investor Cheat Sheet

Stock Investor Cheat Sheet®

The ultimate Cheat Sheet for finding winning stock picks.
Learn More

Gold & Silver Newsletter

Gold & Silver

Don't miss one of the biggest bull markets in history! Covers Gold, Silver, Gold & Silver stocks, and miners.
Learn More

Commodities Premium Newsletter

Commodities Premium

There's always a bull market in some sector! Find the best opportunities in commodities.
Learn more

ETF Investing

ETF Investing

At last, a trading system that buys the right ETFs at the right time, time after time!
Learn more

Yahoo Finance, Harvard Business Review, Market Watch, The Wall St. Journal, Financial Times, CNN Money, Fox Business